Melphalan and its role in the management of patients with multiple myeloma. - Wikidata - wikimedia - TriplyDB

Melphalan and its role in the management of patients with multiple myeloma.

Melphalan and its role in the management of patients with multiple myeloma.

http://www.wikidata.org/entity/Q36879132

about

The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies.Drug resistance and cellular adaptation to tumor acidic pH microenvironment Mixed ligand copper(II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity.Induction of chemoresistance by all-trans retinoic acid via a noncanonical signaling in multiple myeloma cells.Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma.Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma.Nuclease and anti-proliferative activities of copper(II) complexes of N3O tripodal ligands involving a sterically hindered phenolate.Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells Melflufen - a peptidase-potentiated alkylating agent in clinical trials.Covalent adducts of melphalan with free amino acids and a model peptide studied by liquid chromatography/tandem mass spectrometry.

P2860

Q34448863-ABCCCA8D-A5DF-4A91-9A18-1D4727D6FF72 Q34501199-76803D0A-AC08-495C-9271-CCB33B1FE405 Q35592647-90B8DC7D-F2CB-4425-A7FC-4DC51AE5727E Q35625019-FF73BAAB-6A55-4E72-ADBC-0186873BF014 Q37458756-A3DBA37F-D0D6-413E-B8A4-0EA2E7D7FB1D Q37509136-E6AE640F-6634-4D4C-8A99-BE229985F207 Q38526452-962F3699-4E40-44FB-9F42-9906F52BB50A Q39159203-4DBD388E-974C-4D0D-A3E6-D8018681E9AB Q39181854-0B3FA9FB-345C-44BA-AE3B-C747018289BC Q42371678-54C0A55B-92BD-4886-AF27-3B1F316697B1 Q53180850-547A362F-7D14-48C2-AD50-19A6772E53D2

P2860

Melphalan and its role in the management of patients with multiple myeloma.

http://www.wikidata.org/entity/Q36879132

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Melphalan and its role in the management of patients with multiple myeloma.

@en

type

label

Melphalan and its role in the management of patients with multiple myeloma.

@en

prefLabel

Melphalan and its role in the management of patients with multiple myeloma.

@en

P1433

Q36879132-401FE853-DDA1-4499-922B-F5243B232B07

P1476

Q36879132-CAB07BE5-DEF5-49BC-9C9F-B191B1B8ADE6

P2093

Q36879132-295D06B2-18ED-42F5-B72C-671C6A72CF9A

Q36879132-4421AF30-7E4F-4323-BF2E-F8C3189A69EB

Q36879132-9E5314AA-A18A-4E3A-955E-AD3375E69156

Q36879132-B1D90F09-DB48-4E95-B092-01A26B211308

Q36879132-B2ACA516-6ACC-4A2D-9A86-C629E44CDC9C

P2860

Q36879132-05F38280-1BBE-43CB-B139-F93585F30F83

Q36879132-0FC1E707-5BDF-4E04-85AA-1A91546D8393

Q36879132-1AD8F667-4F83-4669-A834-01DD23090282

Q36879132-23D3BC56-A473-49E0-AF93-332064C10E88

Q36879132-3112531E-6B7E-46E0-83A4-14CDB51FC43C

Q36879132-358BD8D0-1763-4D38-8EAD-C0F9EE8ABC3B

Q36879132-3AB0920A-35E8-47F5-961D-F20F644C1A13

Q36879132-3E6DEB0D-CD81-46B3-903A-3BDF49A3CB44

Q36879132-40C5AD17-E550-43EA-A212-E7399CC246F9

Q36879132-4275C001-A5F8-49B8-84B6-4C04135792A0

P304

Q36879132-EE0FF132-0D6D-4413-8947-234D72BF96F3

P31

Q36879132-5493218D-AFD1-479D-8581-CAE799B7E24B

P356

Q36879132-308B35F7-110C-4CE1-9D22-9BC660006C18

P433

Q36879132-BA0D9F3F-4ED6-48CF-B68C-2AE0B93308E8

P478

Q36879132-BA5F8448-AF5E-4428-9773-477A02C6A20E

P50

Q36879132-4386C05E-351C-4A63-80E5-01D82CD36183

Q36879132-A8EC1EA5-F38C-4749-8F0C-AB1DFF179351

P577

Q36879132-0C671B13-6BA0-4F86-81B2-132D24E9B397

P698

Q36879132-A8A4DD13-18FE-4DC5-93C3-882C94C6D54D

P356

14737140.7.7.945

P1433

Expert Review of Anticancer Therapy

P1476

Melphalan and its role in the management of patients with multiple myeloma

@en

P2093

Fortunato Morabito

http://www.w3.org/2001/XMLSchema#string

Ilaria Avonto

http://www.w3.org/2001/XMLSchema#string

Mario Boccadoro

http://www.w3.org/2001/XMLSchema#string

Patrizia Falco

http://www.w3.org/2001/XMLSchema#string

Sara Bringhen

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma.

The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma.

Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

Identification and validation of novel therapeutic targets for multiple myeloma.

P304

945-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.7.7.945

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Palumbo

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17627453

http://www.w3.org/2001/XMLSchema#string